MetaOptima has been announced as one of twelve women-led Canadian companies to participate in the Women In Tech Silicon Valley Program! We couldn’t be more excited for the opportunity to participate in programs designed to support women entrepreneurs in expanding their business outside of Canada!
You’ve made the decision to upgrade to a new dermatology software. What happens next? Training, go-live dates, and achieving key milestones all matter, so how will your software provider ensure your practice reaches its full potential?
It's National Skin Cancer Week in Australia! GPs have over 1 million patient consultations per year for skin cancer.1 On the front lines in providing care and spreading awareness, how can professionals ensure patients receive the care they need while staying engaged in their skin health plan?
Healius Limited has gone live with MetaOptima Technology’s DermEngine software across its Skin2 doctor-led service dedicated to the diagnosis and treatment of skin cancer.
DermEngine rolls out across Australian Skin Cancer Centre clinics.
MetaOptima Technology Australia Pty Ltd has signed a national agreement with Sonic Healthcare to implement the DermEngine software across the Australian Skin Cancer Centres and IPN Family Medical Centres network.
Dermoscopy training: what comes to mind? Challenging those who would say “boring” or “exhausting”, the Skin Cancer Symposium hosted a 2-day power session designed to engage care providers with hands-on lessons, group sessions and quizzes for maximum effectiveness. 2019 brought a surprise twist.
AAFP is underway! From September 24th-28th family physicians from across the globe are gathering together in Philadelphia to earn CME, network, and learn about new patient-centric care solutions! Come visit the DermEngine team at booth #326 to see how DermEngine is supporting this initiative!
The prevalence of AI technology in dermatology practices is undeniable and, to some extent, unavoidable. Seeing AI algorithms as smart assistants is proving to be the best way to understand the potential behind real-life scenario implementation of this technology.
Every day, new, exciting technologies are released that support medical professionals in providing quality services to their patients. How can their success be measured? Efficacy? Affordability? Quality? All key indicators, there is one important piece of criteria that’s often missed: patient satisfaction.
As the rates of skin cancer cases continues to rise at an annual rate of 7.7%, dermatologists, GPs and other medical professionals are unable to meet the growing need for detecting this disease at the earliest possible stage for optimized health outcomes.
As a global company, MetaOptima strives to equip medical professionals with intelligent solutions that fit the needs of their practice. To further this initiative, we are pleased to announce a partnership with DermDetect to support our mission of providing accessible skin imaging services.
The healthcare industry has been criticised for its use of stale practices due to its complex environment and resistance to change. However, current initiatives in dermatology are pioneering how technology can offer substantial improvement to provide streamlined care.
Skin cancer is something that affects us all. Accounting for one third of all cancer cases, the number of new diagnoses is rising at an alarming rate, increasing by 7.7% in 2019 alone.1 In addition to being the most common form of cancer, it is also one of the most treatable.
From August 14th to 17th, the MetaOptima team is pleased to present our latest innovations for intelligent dermatology at the 8th Annual American Dermoscopy Meeting (ADM), at the beautiful Omni Homestead Resort in Hot Springs, Virginia.
MetaOptima is thrilled to announce that DermEngine now offers complete integration services for Epic users. Combining the features of both platforms for coordinated, interoperable and effective care is now easier than ever.
The power of artificial intelligence (AI) for the classification of pigmented skin lesions is raising promising results, showing great potential as a collaborative tool to refine the accuracy of medical professionals in identifying skin conditions such as melanoma in a clinical setting.
Diagnosing and treating a medical anomaly makes time a crucial variable. Skin conditions are no exception, with the early detection of skin cancer being the most important factor for saving patient lives from this disease.
As the World Congress of Dermatology 2019 is set to start next week, the MetaOptima team is looking forward to sharing the latest updates and newly released tools of our AI-driven platform, DermEngine. Meet us at booth E04 to experience our vision on the future of intelligent dermatology.
The MetaOptima team is filled with excitement as the World Congress of Dermatology quickly approaches. Join us at Milano Congressi, from June 11th to 14th at booth E04 to learn about the latest trends in intelligent dermatology as we present DermEngine’s newest features.
The MetaOptima team is excited for the opportunity to exhibit during the upcoming 2019 edition of Hospitalar healthcare tradeshow in São Paulo, Brazil. Additionally, we’re pleased to announce that our Chief Growth Officer, Manoel Coelho will be one of the speakers at CISS conference and HIMSS @ Hospitalar Forum.
MetaOptima is thrilled to announce that our team will be on the ground for the upcoming Hospitalar 2019 tradeshow. From May 21-24 at the Expo Centre Norte in São Paulo, we would love to meet you at booth #52 to discuss our intelligent dermatology products and services.
Total Body Photography (TBP) is known to be performed by certain practices that have the financial luxury and space to invest in a premium medical tool. How can a greater number of practices gain access to this key piece of technology for the early detection of skin cancer?
AI: at the very mention of these words, new ideas involving the major transformation of human lifestyle since the industrial revolution may come to mind.1 In the extremely fast-paced development of AI tools, their influence is set to change how health services are experienced by providers and patients alike.
2018 introduced the push for patient-centred care, equipping medical professionals with the tools to focus on their patients (not the process). As dermatology technologies continue to evolve, how can this be expected to shift to patient-centric care?
Patient-centric dermatology services depend on initiatives that can tackle not only skin conditions themselves, but also offer smooth workflows which support patients in their journey through the healthcare system to boost efficacy in treatment outcomes.
The 26th Annual American Telemedicine Association (ATA19) Conference has officially closed! The MetaOptima team met with lots of medical experts and enthusiasts who were thrilled to discuss the latest teledermatology trends targeted at improving patient outcomes by facilitating a streamlined health ecosystem.
Today marked day one of the American Telemedicine Association Conference held at the Ernest N. Morial Convention Center in New Orleans. If you haven’t already, be sure to visit our team at booth 932 to chat with us about how DermEngine’s teledermatology features best fit your professional needs!
Dermatologists are already stretched thin, with 623 specialists serving Canada’s population of over 37 million and many rural areas left without a professional at all.1 How can DermEngine’s artificial intelligence-based tools assist medical professionals quickly and effectively serve high-priority patients?
The MetaOptima team is thrilled to take part in the next American Telemedicine Association 2019 conference (ATA19) on April 14-16 at the Ernest N. Morial Convention Center in New Orleans. Be sure to visit us at booth 932 for a chance to learn about our products and services!
DermEngine utilizes the latest innovations in artificial intelligence (AI) to provide its users with cutting-edge technology for imaging, analyzing and documenting within their daily practice. As part of our initiative to provide innovative services, we'd like to take this opportunity to answer your important questions about our algorithms and their usage within DermEngine.
Unfortunately, positive patient outcomes and financial areas in healthcare have been suffering due to medical readmissions. Teledermatology services are now able to reduce these harmful repercussions by overcoming proximity barriers to serve individuals in need of quality care while supporting the early detection of skin cancer.1
In the past, the practice of dermoscopy was limited to the dermatologist- after all, it is the tool of their trade. The drawback of this framework means that dermatologists are stuck doing the heavy lifting (imaging, administrative work). How can other healthcare providers relieve this pressure?
Rather than just being associated with ‘Bitcoin’, the popular cryptocurrency, blockchain has the potential to transform how all transactions are completed. By 2025, blockchain will have a projected value of $5.6 B in healthcare alone - an estimate drawing attention from stakeholders across the globe.1
MetaOptima’s Research and Development team has been honoured with the ISIC 2018 Challenge for Skin Cancer Classification award. The team successfully earned first, second, and third place within the competition for their three submissions.
Cancer is never a positive word to hear when it comes to a medical diagnosis. However, in a technology-dominated era, when any abnormal symptoms arise, patients tend to look for immediate answers on general, accessible search engines rather than specialized healthcare websites.
As part of MetaOptima’s initiative to develop and implement intelligent dermatology software and tools designed to support medical professionals in their daily practice, the company’s Research & Development team has published the following research papers.
Europe’s pass of the General Data Protection Regulation (GDPR) last May brought many changes to the way information privacy is to be handled, with a particular focus in the handling of healthcare data.1 This article will discuss how the features and tools available in the dermatology software DermEngine are compliant with GDPR for maximized security and privacy.
EMR software (electronic medical records) is the basis of a dermatologist’s practice; it documents the patient’s visit, stores their medical history, and centralizes all associated media relating to their file. Why is it so hard to find a system that keeps up with current needs?
Creating efficient workflows and disrupting workforces are two topics that spark decision makers to ask: “How does this affect my industry?” Healthcare providers are among those who are looking for ways to improve patients’ healthcare journey throughout medical systems using artificial intelligence.
MetaOptima is thrilled to be the official host for the Supercluster’s Round 1 project announcement today at the company’s Vancouver headquarter offices. This event included Supercluster team members and the special presence of Mr. Navdeep Bains, Minister of Innovation, Science and Economic Development (ISED).
Another successful year at AAD! Although the last day, it was not without excitement as attendees rushed to see every last booth. The MetaOptima Team had the pleasure of seeing many familiar faces as people returned to purchase DermEngine and pre-order their very own MoleScope III.
MetaOptima’s team is currently in Washington DC for the annual American Academy of Dermatology (AAD) conference running from March 1st-3rd. Visit us on booth #4320 to take a look at some of the most advanced technology tools in dermatology.
Image. Analyze. Document. If you were to summarize your daily imaging workflows would this be it? Or would it be closer to: Find missing patient chart. Image with standalone dermoscope. Manually upload & add data to EMR. Re-add paperwork. Diagnose.
The Comprehensive and Progressive Trans-Pacific Partnership (CPTPP) looks to potentiate the free-trade business and stimulate tax-free international commerce among members. Officially signed in March 2018, this agreement brings together a block of countries comprised of Canada, Australia, New Zealand, Mexico, Japan, and other pacific nations amounting to a net worth of 13.5 trillion dollars, the world’s third largest of its kind.
Part I of this article discussed how in spite of teledermatology’s relatively short history it rapidly became a widely used technique. Compounding its innovative remote telecommunication features since the mid 1990s has optimized operational efficiency making it a practical component of practices worldwide.
AAD 2019 is just around the corner! From March 1st-5th the MetaOptima Team will be in Washington, DC the largest dermatology conference in the US. Be sure to come visit us at booth #4320- whether you’re a dermatologist, GP, or industry expert we have something for you!
Our Australia team will be participating of the upcoming Professional Certificate of Skin Cancer Medicine these February 23rd & 24th in Melbourne. This course is designed to equip GPs with a powerful practical approach on how to diagnose and advise on melanoma and other skin conditions.
Due to the dermatologist shortage, GPs and other healthcare providers are on the front lines in the fight against skin cancer. As primary care physicians are managing an additional number of dermatology cases, what can technology do to support them?
HIMSS 2019 ended as quickly as it had begun. Leaving attendees with a feeling of excitement, the MetaOptima Team spent the final day introducing industry experts to the latest features to DermEngine’s intelligent dermatology tools for best practice.
Teledermatology has become one of the fastest growing fields within telemedicine for its advantages of servicing a wide prospect of patients. Part I of this article will discuss teledermatology’s brief history alongside its current uses and challenges in the health industry.
A term more often associated with politics than technology, democracy has crossed boundaries to healthcare information management. Referring to the integral understanding of how big data is used from a business standpoint, data democracy will be essential towards the widespread adoption of AI in healthcare.
The MetaOptima Team had a busy first official day at HIMSS 2019 in Orlando, Florida meeting with industry experts and chatting at our booth (#6884) about how DermEngine is pioneering some of the latest advancements in health IT with tools like artificial intelligence (AI) and interoperability.
Today marks the first day of HIMSS 2019 in Orlando, Florida. Off to an energetic start, the MetaOptima Team had a busy start building and assembling our booth (#6884) in preparation for the big week that awaits of showcasing DermEngine (our intelligent dermatology software).
Health IT: an area of virtually endless growth (and frustrations) which has become a central hub for innovation. With HIMSS 2019 just around the corner, it’s time to take a look at some of the most anticipated sources for innovation at one of the biggest global health conferences.
The MetaOptima Team is thrilled to officially welcome Manoel Coelho as its Chief Growth Officer. Mr. Coelho joins MetaOptima with a solid background in the healthcare industry with more than 15 years of experience in the telemedicine field alongside vast multinational business expertise.
A common goal for healthcare enterprises around the world is to provide the highest quality of care to their patients. As a result, telemedicine software companies are driven to provide solutions designed to support healthcare providers in offering connected, streamlined care.
MetaOptima will be attending HIMSS Health IT Conference 2019 in Orlando, Florida. Held at the Orange County Convention Center, you can visit booth 6884 to have a live demo of DermEngine and MoleScope and chat with our team members about the latest innovations in Health IT.
Health information management constitutes one of the pillars of current health practices across various fields. In dermatology, regulations for the collection, storage, release and disposal of patient information is based on government policies to guarantee that every stakeholder strictly observes the legislation established.
Dermoscopy: known for its ability to increase the diagnostic accuracy of skin conditions such as melanoma, comes in many forms. Most recently is the introduction of mobile dermoscopy for in-home imaging by patients. What can medical experts do to convince patients that this is the next step in receiving affordable, quality skin care?
In order to remain competitive, businesses need to use their resources efficiently to serve as many customers as possible. The same goes for dermatology practices. As a response to competitiveness, dermatologists are looking to digital solutions to increase their patient-serving capabilities. Software such as DermEngine use this growing trend known as teledermatology, where doctors are able to serve more patients across wider regions.
Total body photography (TBP) has grown in popularity given its impact on skin cancer early detection.1 This article will review solutions to overcome current operational challenges for the broader accessibility and implementation of this technique in the future.
Have you ever been placed in the unfortunate situation where an emergency requires you to retrieve a patient’s file from your clinic after hours? If you have, then you know the stress this creates for everyone involved. How can cross-platform accessibility overcome this barrier?
Access to dermatology services can be a challenging experience for patients based on the current shortage of qualified dermatologists available. With the introduction of new health technologies, patients are now able to receive care more quickly and easily than ever before.
Natural Language Processing (NLP) is a $16 billion market opportunity positioned for great innovations in the healthcare sector. 1 Designed to create comprehensive documentation solutions, this niche artificial intelligence (AI)-based solution is already revolutionizing how data is utilized.
MetaOptima is well underway in its preparations for the annual HIMSS Health IT conference. Held in sunny Orlando, Florida from February 11th-15th, our team will be at Booth 6884 discussing the latest tech trends from interoperability to cyber security along with how DermEngine is part of the overarching solution of a comprehensive, connected health plan.
In Part 1 of this article, regulatory areas for the practice of live-interactive (LI) teledermatology were outlined as directed by the AAD’s position statement. The other common form of teledermatology practices, the Store-and-Forward (SAF) approach, follows similar regulations in order to guarantee the highest levels of care to patients.
Teledermatology constitutes a growing trend in general dermatology services favoured by the advantages of remote connectivity to reach patients in a timely and efficient fashion. However, technical and regulatory challenges need to be addressed to guarantee quality and safety.
Artificial intelligence (AI) has rapidly become the centre of attention for the technological development of a wide range of activities. Healthcare is no exception, with a particular focus in dermatology services to assist in the identification of skin diseases. This article aims to discuss how revolutionary trends in AI development are contributing to a greater understanding of both its operational nature and projected impact in the dermatology industry.
It is quite fascinating to see how patient management systems are so heavily influenced by technology. It wasn’t long ago when even transferring a patient's medical history to a physician in another city wasn't practical. In contrast, many new digital health platforms are focused on more effective and secure communication between patients and healthcare providers for a simplified practice experience.
Total Body Photography: although only implemented within the past couple of decades, it has become a pillar for dermatology practices focused on the early detection of skin cancer. Introduced in a time of rapidly evolving technology, how has it improved and what goals remain unachieved?
When adopting the use of mobile devices within your practice it is essential that all regulations are strictly adhered to. To support this process, the following guide outlines the key legal issues to be aware of in Australia before using a mobile device to take clinical images when providing care.
Part 1 of this article described 5 common facts surrounding teledermoscopy and its benefits to improving teledermatology services. Part 2 will focus on discussing the myths that detract its utility while reaffirming the advantages of a broader implementation of this technique in daily practices.
It is with warm hearts during this festive season that we take the time to reflect and be thankful for everyone who has made our success possible. We'd like to take this opportunity to share with you all that we have accomplished this past year thanks to your continued support and feedback!
Despite the benefits brought by teledermoscopy and the ease with which it can provide dermoscopic images from patients with poor access to in-clinic professional skincare,1 there is still some confusion about the scope and utility of this practice. Part 1 of this article will discuss the benefits of the widespread use of teledermoscopy as a complementing service to personal consultations by looking at the the common facts around this topic.
Patient medical records are perhaps the most vital component when providing comprehensive, evidence-based care to those in need. Without an EMR (electronic medical record) system, healthcare experts would be left in the dark. Naturally, one might presume that EMRs serve to remain accessible, accurate, and interoperable at all costs.
The concept of big data is becoming increasingly familiar across many fields of human activity.1 Data mining in numerous disciplines has become a source of enormous amounts of information, a trend that has also reached healthcare. The vast amounts of data collected are helping to draw behavioural patterns able to support future disease management.
Teledermatology services have been in the rise in the last decade. This practice has rapidly spread in many countries given its ease of utilization and the advantage to serve remote areas.1 Underserved populations with restricted access to traditional dermatology consultations have been greatly benefited, consequently driving teledermatology expansion.
The upcoming decade will mark a drastic change in the primary demographic in need of healthcare; by 2025 ~25% of the population will be over the age of 65.1 With such large changes already beginning to take effect, how will this alter the dermatology industry?
Dermatology services represent a multifaceted process, where professionals from several disciplines become involved in providing a final diagnosis. However, a multidisciplinary approach can become a substantial barrier if communication is not exercised correctly.
Part 1 of this article reviewed a case study regarding a UK-based clinic which implemented teledermoscopy services for streamlined care. Although staff reported that “patients received care far more quickly”, the practice was running at a slight loss in spite It is interesting to note that physicians reported using the services to practice their dermatology skills by including a “guess” diagnosis when referring to a dermatologist.
Patient dermatology data constitutes the most important piece in the healthcare puzzle. Relying on clean, precise and trustworthy data is the beginning of the quest to tackle any patient’s health concern.1 The ability to gather and condense high-quality data in a central, interconnected and highly-accessible online hub is becoming the norm for modern dermatology services.
Teledermatology (with a focus in dermoscopy) is becoming a widely-cited solution for lowering healthcare costs while reducing patient wait times. How accurate is this statement? The following article compares two studies which focus on the financial feasibility of providing teledermoscopy services to patients as an e-triage solution.
Dermatology electronic medical record (EMR) software have become a basic tool for everyday dermatology practices.1 The power to collect, analyze, share and store crucial patient data makes them a staple piece of dermatologists’ work. This article will describe how the use of cloud-based EMRs is transforming the way patient data flows.
Cloud computing is something we hear about in nearly any industry; whether in healthcare, business, or personal life the cloud always seems to have a place. Due to its rapid increase in popularity as a solution for data storage and management, many medical professionals may feel left in the dust. After all, who wouldn’t be with such an overwhelming amount of knowledge and change? The following article looks to address the top 3 most common myths & questions of using cloud EMRs in healthcare.
Total Body Photography (also known as full-body imaging) is a widely recognized method for monitoring patients with a large number of spots or increased risk of developing skin cancer. Unfortunately, within this solution presents the challenge of requiring the patient to consistently visit the clinic for imaging sessions.
Artificial intelligence is undoubtedly the new focus of technological development. The concept of utilizing machines to automate a myriad of human processes has fascinated humanity for a long time, but never has it been as realistic as today in terms of practical applications across various fields, including dermatology.
Technology has infiltrated nearly every aspect of our lives. However, what may be welcomed as a valuable resource to some is seen as an overwhelming challenge for others. In a world where nearly everything is digitally-dependent, how has this impacted the healthcare sector’s ability to provide life-saving care?
Dermatology EMR systems are the primary technological platform doctors utilize to handle patient information. Ongoing developments in this field have allowed for the improved management and optimization of data access and storage.
Teledermatology (a branch of telemedicine specializing in cases relating to the skin) has become a popular solution to address the growing number of documented skin conditions such as melanoma. As these services have become more widespread, medical professionals are beginning to offer the solution in a wider variety of spaces. What are these settings and why have they encouraged the growth of teledermatology where regular in-office visits failed?
Teledermatology is the branch of telemedicine that utilizes communication technology to offer dermatology services over the internet. More recently, the advent of dermoscopy in traditional practices has also transpired into online platforms, making teledermoscopy services even more widely available. This article will review the benefits and impact of teledermoscopy practices in teledermatology services answering five most asked questions.
EMR software solutions have penetrated nearly every healthcare sector, with more than 80% of medical professionals reporting using it within their practice.1 In spite of this great advancement, one key challenge remains: the vast majority of these systems cannot efficiently transfer data between one another. Known as interoperability, this criteria is proving to be a key factor for medical professionals determining in whether an EMR software will be able to meet their professional needs.
Dermatology practices have been witness to rapid changes in technology for optimized care.1 The increased connectivity caused by widespread internet networks has allowed for the implementation of cloud services with remote accessibility, known as software as a service (SaaS) systems. This article will review the increasing expansion of SaaS in healthcare and how AI is set to make them more efficient and interoperable platforms for improved skin care services.
Skin cancer is a problem that affects us all, with one in seven Canadians developing a form of the condition within their lifetime.1 In spite of the widely recognized importance of prevention and early detection, the rates of melanoma continue to increase. Overwhelmed with cases while facing a profession shortage, dermatologists are struggling to keep up with the race against time because skin cancer doesn’t wait.
Announced in late 2017, Canada’s Digital Supercluster project is a nationwide initiative looking to drive ambitious technology projects. Today’s launch event marks the beginning of Phase 1 of the 3-year program funded with $153 millions from the Ministry of Innovation, Science and Economic Development (ISED).
No matter what sector, research indicates that medical professionals can’t seem to let go of the fax machine. Part 1 of this article summarizes the top four reasons behind this decision along with the largest challenges currently faced by healthcare workers. Building on these discoveries, the following segment will unpack the flaws behind the most revered traits of these machines.
Fax machines have long held a place within the healthcare system for relaying important information. On the eve of digital healthcare innovations, it is astonishing to learn that this outdated hardware still possesses such a strong hold within the industry- so strong in fact that it is becoming detrimental to the healthcare industry’s efficiency and quality of patient care.
Artificial intelligence (AI) refers to the capacity of machines to think, reason and perform cognitive processes much like any average human being does.1 Despite the relative delayed adoption of AI in healthcare environments, machines are already making their way into hospital and clinics, including dermatology practices. However, the changes introduced by this new technology are raising various degrees of opposition in the field.
Today marks day three of National Skin Cancer Action Week in Australia (held from Nov. 24th-28th). With 2 in 3 Australians diagnosed with skin cancer in their lifetime, this is an important opportunity to educate people about the importance of both prevention and early detection.
Dermatology software are technology-driven platforms built to improve the way doctors collect, analyze and store patient information for accurate case study. Furthermore, the rapid development of technology is transforming the way dermatologists rely on EMRs for skin cancer early detection. This article will present some of the features that are transforming modern EMR systems into best allies for the fight against skin cancer.
Recently, 49% of surveyed medical industry personnel indicated that patient engagement is a major priority over the next five years.1 Although clearly identified as an area of great importance, a snapshot of the current healthcare industry demonstrates that this unfortunately fails to be the case. This article summarizes the key reasons behind the importance of patient accessibility along with the consequences of disconnected communications and care.
Teledermatology refers to the practice of dermatology online without the initial need to see a physician in person. This industry, with a record expansion of more than 600% in recent times, is expected to be worth $7 billion by 2020.1,2 The power of connectivity offered by these systems supports the readiness of interaction between patients and doctors and provide a great platform to add teledermoscopy services to their practice.
Within digital healthcare are millions of intricate pieces that comprise what is today’s care system. One of the core pieces of this elaborate scheme are human relationships: patients interacting with their physicians, doctors with their colleagues, and (perhaps the most ambiguous) medical professionals with health technologies.
Dermatology electronic medical record (EMR) software have changed the paradigm of patient data collection, management and storage. They have streamlined workflows and added efficiency to practices, however, their operational efficacy is still a developing area. To date, no single EMR is capable of achieving all expected tasks on its own.
Electronic Medical Record (EMR) software have become a pillar of many medical practices, including dermatology. Despite the advancements brought, dermatology is experiencing a drop of active practitioners in countries like Canada and Australia.1,2 Considering skin cancer has higher survival rates if diagnosed at early stages, this translates to unrealistic waiting times for patients.
Artificial intelligence in dermatology is being introduced throughout every aspect of the industry, from dermoscopy all the way to predictive analytics.Amid all of these astounding advances, which ones are set to have the greatest impact on dermatologists, their practice and (most importantly) their patients?
Mobile dermoscopy has introduced positive changes to the way traditional dermatology examinations are performed.1 Dermoscopes allow dermatologists to obtain magnified images of the skin to a level of detail that greatly aids in determining the nature of lesions.2 As a result, patient-oriented mobile dermoscopes have been designed for patients to perform high-quality self-examinations.
Within the ever-expanding complexities of the healthcare system one component stands above the rest in importance: the patient. In order to provide accurate, informed care patient medical files must be as up to date as they are accessible. Discover why in spite of the latest advancements to dermatology EMR software solutions this fails to be the case along with what healthcare providers are doing to combat this crisis.
Artificial intelligence (AI) is driving the development of many industries through a revolution in machine learning technology.1 Within dermatology practices, beyond its proven capacity for assisting in diagnostic procedures, these deep learning algorithms are also posing questions regarding the extent of automation in doctor-patient relationships along with the associated ethical implications.
Dermoscopy is an integral part of any dermatology practice. Shown to increase diagnostic accuracy of skin cancer and other conditions by as much as 35%, this tool represents some of the most innovative solutions introduced to the dermatology industry. Discover the top three ways mobile dermoscopes in particular are shown to streamline professional workflows for maximized efficiency.
Artificial intelligence in dermatology has become a constant source of news and excitement. Among all of the information, it can be challenging to differentiate reality from fiction, especially when determining how it may impact your practice. Read on to discover the answers to 6 of your most asked questions about artificial intelligence for dermatology and what it means for you.
Just as with many other fields, dermatology has undergone profound changes in the last decade driven by the advent of new technologies. Among major changes is the adoption of refined electronic medical records (EMR) software that support telemedicine services, a field that is estimated to reach $7 billion by 2020.1,2 This article will focus on the latest trends experienced in the dermatology field that are revolutionizing the way practices are offered to patients.
MetaOptima is excited to announce its sponsorship of the International Certificate of Dermatoscopy and Skin Cancer Medicine event held October 27th-28th in Oxford, UK. As part of this initiative, we are excited to announce that every member will be receiving a complimentary 1-year subscription to DermEngine (intelligent dermatology software) and a free MoleScope II (mobile dermoscope)!
MetaOptima’s CEO Maryam Sadeghi will be participating in the 2018 Continuing Medical Education (CME) symposium taking place on October 25th at the Memorial Sloan Kettering Cancer Centre in New York City. As this year’s curriculum will focus on the potential of technology to advance the dermatology practice, Maryam will be joining a group of experts in the industry to share on the future of connected intelligent dermatology.
Dermatology EMR software is an essential component of ~80% of practices in the United States.1 As a clinic, hospital, or service’s needs expand or evolve over time, it is essential that all professional software supports these changes- not hold them back. Read on to learn three key reasons your EMR should always be scalable to your practice.
Dermoscopy use in dermatology has been on the rise in the last decade due to its practical advantages for the diagnosis of skin conditions.1 Statistics show that dermoscopy has the potential to outperform traditional methods for skin lesion examination in efficacy (melanoma detection)2 and unnecessary biopsies reduction.3 This article will summarize the top seven features that are driving the latest trends in dermoscopy as a crucial component of modern dermatology services.
Teledermoscopy services are quickly becoming a solution to many of healthcare’s growing problems, such as patient accessibility, pace of care, and costs. What are the next steps? Discover why dermatology EMR software are already combining teledermoscopy services with artificial intelligence for a new level of comprehensive care.
Dermatology medical records are an important part of a patient's care plan, however until very recently patients often couldn't access their information. From 2014-2017, patients’ ability to access their medical records has jumped a whole 42%.1 This results in better informed patients who contribute to improved healthcare awareness.
MetaOptima is excited to announce its partnership with Change Healthcare to develop and implement an intelligent dermatology software network with the support of DermEngine and MoleScope for improved patient care across Canada. Expected to roll out across British Columbia from 2019-2020, this is an exciting opportunity to extend affordable, accessible, and streamlined dermatology care to all patients.
Dermoscopy is becoming common practice in dermatology services, as magnified skin imaging proves to increase diagnosis accuracy and reduce unnecessary biopsies.1,2 However, before a dermatologist can begin utilizing a dermoscope, he must determine which technical characteristics will best suit his imaging needs. This article will present an overview of the current status of dermoscopy while comparing features of mobile dermoscopes.
EMR systems are experiencing huge upgrades throughout the healthcare industry. So why do 80% of doctors report using their phone to support their practice?1 Argued to simplify communications and bring healthcare into the 21st century, read on to learn why this can pose a threat to patient privacy and quality of information.
Dermatopathologists specialize in skin-related diseases to support the work of dermatologists.1 However, constraints in patient data sharing of traditional record systems pose challenges on the effective communication between these professionals. This article will focus on the features available on cloud-based electronic medical record (EMR) software to overcome these difficulties and offer seamless workflows for disease diagnosis.
Within each dermatology clinic is the potential to change the way people think about their skin health. Not just through regular skin checks and skin cancer awareness brochures, but having patients become engaged in their care plan. With mobile dermoscopy tools sweeping the industry, this is quickly becoming the norm.
Artificial intelligence (AI) is transforming the way we conceive everyday life, from voice-operated personal assistants to customized streaming services 1. Although less obvious, AI has also started to play a pivotal role in the way healthcare services are offered. This article will evaluate the impact of AI in dermatology to assist in dermatologists’ skin cancer diagnosis.
Total body Photography is set to be one of the next big technologies in dermatology. Although a massive improvement from traditional imaging methods, many systems fail to solve all of the concerns faced by medical experts. Discover the top 5 ways artificial intelligence (AI) is pairing with these systems in dermatology to streamline practices like never imagined.
Electronic Medical Records (EMRs) have been employed to better handle the increase in patient data and the demands for medical history accessibility. However, implementation costs and security concerns are two main opponents to the widespread adoption of EMR software. This article will present the benefits that EMRs have brought while discussing what advantages cloud-based systems can offer to improve cost and safety difficulties.
Healthcare services have been profoundly impacted by the use of electronic medical records (EMR) platforms in recent years, making patients’ medical histories readily available in digital format. However, interoperability among platforms still remains a barrier. In this article, the nature of interoperability will be discussed alongside the current approaches to overcome these challenges.
In 2018, we’ve developed smart systems for heating, lighting and security. What about healthcare? With the desperate need for more efficient practice workflows and shorter patient wait times, intelligent technologies hold immeasurable potential to forever transform the way medical professionals provide their care.
Since early ideas about the development of intelligent machines were discussed in the 1950s, the field of artificial intelligence (AI) has experienced exponential growth. Currently, the use of machine-assisted procedures has expanded to virtually all industries, including the field of dermatology. This article will discuss the applications of artificial intelligence in dermatology while presenting its implications for the patient-doctor relationship.
With the growing disparity between patient needs and available number of dermatologists, it is essential that medical professionals are equipped with the most advanced tools in dermoscopy in order to provide the utmost quality of care. This article reviews the experience of Dr. Jason Rivers, a practicing dermatologist at Pacific Derm in Vancouver, Canada using DermEngine with the support of MoleScope for his patients.
In the past few decades, Software as a Service (SaaS) has arisen as a new operational business model that has successfully integrated into various disciplines. Projections predict it will end the year as a $127.5B industry.1 This article will describe the technical benefits offered by the SaaS solution in healthcare enterprises with a focus on dermatology.
From September 26th-29th MetaOptima's certified distributor, Inpharamo will be attending the 10th annual conference of the Mexican Society of Dermatological and Ontological Surgery in Guadalajara! 1 Our first time attending an event in Mexico, we are confident that this will serve as an excellent opportunity to expand the reach of MoleScope II and DermEngine while discussing how intelligent dermoscopy tools can support practices around the globe.
Are you attending Vancouver Startup Week? Would you like to more about what our team does here at MetaOptima? Come visit us at Vancouver Startup Week today (September 26th) at Science World for an opportunity to chat with seven of our awesome members! (If you haven’t already, sign up here!)
In Part 1 of this article, the many advantages of live-interactive teledermatology were discussed. However, this approach can also present many challenges, rendering it inefficient for certain daily practices. Part 2 of this post will be devoted to describing the nature of the store-and-forward approach for dermoscopic imaging teledermatology and the benefits it offers over the live-interactive technique.
As Canada is faced with an increasing shortage of dermatologists, physicians have become a frequent first point of care for dermatology- related cases. What technologies can doctors use to ensure that they provide quality care to these patients while preserving the time necessary to focus on other cases within their practice?
Technological progress has produced innovative approaches to healthcare practice. Advances such as teledermoscopy software bring the advantage of reducing patient waiting times or even eliminating the need to see a practitioner in person during early examination stages.
Within the past decade, a particular craze has been focused on smartphones, and the (sometimes addicting) apps that can be downloaded. Although some are focused for just gaming, news, or lifestyle choices, how does this new wave of technology fit into dermatology practices? Read on to learn the top three reasons a dermoscopy app can streamline workflows.
DermEngine is known for holding a number of popular features, such as total body photography, teledermoscopy services, and clinical decision support tools (powered by artificial intelligence). But what about all the other tools hidden within the software? Read on to discover the top 10 tools within DermEngine you may not have even known existed!
Recently, the article 4 Ways Telemedicine Is Changing Healthcare1 interviewed two medical experts to determine the top four sectors set to evolve the way doctors provide their care and how patients viewed their experience. Expanding on their conclusions, this article discusses how intelligent dermatology software such as DermEngine are meeting or exceeding this new criteria for the aptly named “virtual health” industry.
Here at MetaOptima, we are proud to offer MoleScope, a portable mobile dermoscopy solution for quality imaging. Did you know that there are two versions of the device? This article highlights the key differences of how MoleScope versus MoleScope II are tailored to the specific needs of patients or medical professionals.
Due to the ever-increasing number of patient cases, EMR software is an essential aspect of dermatology practices1. Following the current trend towards newer cloud-based EMR software, this article will focus on the advantages of integration with the intelligent dermatology software DermEngine for a complementary solution to traditional EMRs.
Recent years have seen a marked decrease in the number of available dermatologists to provide necessary patient care, particularly in Canada.1 This article will focus on how virtual healthcare technologies such as MetaOptima's MoleScope II mobile dermoscope and DermEngine dermatology EMR software play a pivotal role in transforming the teledermoscopy industry as a solution to this growing concern.
From September 6th-8th MetaOptima's Business Development Manager, Karen Meohas will be attending the 73rd Brazilian Society of Dermatology Congress 1 in Curitiba! Our first time attending an event in Brazil, we are confident that this will serve as an excellent opportunity to expand the reach of MoleScope II and DermEngine while discussing how intelligent dermoscopy tools can support practices around the globe.
Patient engagement is a crucial component of an optimized skin healthcare plan. Only one of the ways this can be supported is through equipping patients with the tools to help them take skin imaging into their own hands. This article reviews the experience of three patients using a mobile dermoscope (MoleScope) alongside the associated teledermoscopy app for their skin imaging needs.
Recognized for its promising value within the healthcare system, telemedicine holds a projected value of $5.2 billion by 2020. To better understand the drive behind the demand for this technology, this article will investigate real-world results from one of the fastest growing trends in the digital health industry.
Recently, a report determined that 29% of surveyed healthcare executives believe that telemedicine services are the most promising digital health trend in 2018.1 Already recognized for its important role in lowering costs and increasing workflow efficiency, this article dives into this innovation’s lesser known benefits and potential uses.
From August, 24th-26th, MetaOptima's CEO, Maryam Sadeghi will be showcasing the latest features of DermEngine and MoleScope II at the annual Skin Cancer Symposium held in Auckland, New Zealand. Working alongside the company's Country Manager for Australia, Peter Birch, we are confident this will be an excellent opportunity for the team to share how our technologies can support the practice of dermatologists and other medical professionals!
Cloud-based electronic medical records (EMR) solutions are the gold standard in medical practices when it comes to managing processes and storing patient data. It entails keeping patients' medical data and records on external servers which can be accessed anywhere and on any device, provided there’s an internet connection available.
Lately, there has been a demanding rise in need for secure and highly regulated dermatology EMR software (as demonstrated by the implementation of the General Data Protection Regulation). Recognized as the gold standard for security and privacy, being GDPR-compliant is a necessary goal if a company wants their platform to expand to an international scale. So what happens when a software is GDPR-compliant but falls short of local legal requirements?
Once again the MetaOptima Team is excited to have the opportunity to attend the World Congress on Cancers of the Skin 2018 held in Sydney, Australia from August 15th-18th. Located at Booth #22, Maryam Sadeghi, Majid Razmara, Peter Birch and our distributors, Team Medical, will be showcasing the latest features of DermEngine (intelligent dermatology software) and MoleScope (digital dermoscope) to attendees.
We are pleased to announce that MetaOptima's CEO, Maryam Sadeghi,CTO, Majid Razmara and Country Manager for Australia, Peter Birch are exhibiting the latest features of DermEngine and MoleScope II at the New Zealand Dermatological Society Incorporated Annual General Meeting 2018.
Commonly recognized as a pillar within the healthcare community, pharmacies are a growing source of knowledge and assistance for patients in need of care (from flu shots to blood pressure tests). Most recently, visionary dermatologists are utilizing this trend to offer valuable skin check services via eTriage to patients.
Big data is predominantly a factor in new healthcare technologies. Often paired with artificial intelligence, big data is the concept of using “vast quantities of data” towards greater analysis and intelligence. Due to the nearly unimaginable quantity of information that this data signifies, artificial intelligence algorithms are being created to comb this data for valuable insights.
Currently, dermatologist-pathologist communication workflows are in dire need of an upgrade. Based on hand-written or manual documentation and communication systems, users are experiencing consequence of using outdated technologies within the dermatology industry.
As teledermatology services have gained popularity in recent years, so has the software's benefits. Built on a foundation of streamlining care and increased accessibility, teledermoscopy services such as DermEngine have become a popular example of a service designed to alleviate some of the many pressures found in the dermoscopy industry (such as dermatologist shortages and long patient wait times).
MetaOptima’s Business Development Manager, Karen Meohas, possesses extensive work in spearheading the creation and continued growth of companies extending their reach to new countries. In this article, Karen will provide deep insights into the importance of project management and how to best navigate international expansion in medical and bio technologies.
Have you made the switch to a mobile dermoscope? Although relatively new to the market, these little devices are making big waves in dermoscopy news for their portability, scalability, and accessibility. Read on to discover the six key distinctions that separate a mobile dermoscope from a traditional device and how this benefits dermatologists and their practices.
In recent years, dermoscopy has gone through a countless number of changes. Naturally, these evolutions have had a significant impact on the dermatology industry. This article summarizes the most recent advancements in dermoscopy tools while discussing future directions that these innovations may lead.
Full-body imaging is a method designed to promote the early detection of skin cancer in patients, especially in those at a greater risk. In addition to implementing total body photography services within your practice, it is important that your patients understand the significance of this procedure to ensure they remain comfortable and engaged with their skin care plan.
As the world of digital healthcare continues to evolve, how have the latest innovations been adopted within your practice? With such rapid changes occurring everyday, it might be hard to identify exactly what changes these are. Read on to discover seven key shifts in health tech (with a focus in dermoscopy/dermatology).
As artificial intelligence in dermatology continues to make leaps and bounds, there is an increasing need for additional literature citing the efficacy of intelligent machines in comparison to humans. One such study tested the performance of a convolutional neural network to aid in melanoma detection against a large group of dermatologists. This article looks to examine the applications behind the results of this study and the impact intelligent dermatology software will have on the industry.
With all of MetaOptima's recent accomplishments, we wanted to take this opportunity to talk a little bit about our vision. At its core, we work to empower medical professionals and patients with intelligent tools to promote the early detection of skin cancer and optimized care. With both increasing rates of skin cancer and breakthroughs in AI/artificial intelligence, we'd like to share more about MetaOptima's vision in the fight against melanoma starting with Australia.
Funds will be used to implement and build its intelligent dermatology platform DermEngine into the global dermatology industry beginning with Australia.
MetaOptima Technology is pleased to announce that it has raised $8.6 million CAD ($6.5 million USD) to expand its advanced dermatology and skin cancer imaging and management software, DermEngine™, into global markets. This marks a key advancement in the way skin cancer is screened, detected, and managed.
MetaOptima is pleased to announce that DermEngine™, the world’s most advanced skin imaging and analytics tool, has officially been launched in Australia, marking an important advance in the way skin cancer is screened, tracked and detected.
Recently, MetaOptima received a $6.5 million USD ($8.6 million CAD) investment from Australian-based company Skip Capital, co-founded by Atlassian’s Scott Farquhar and Kim Jackson, along with venture capital firm AirTree led by co-founder Daniel Petre.
Within your practice you likely have a wide variety of systems at your disposal, each performing their own specific task. Although each software (ideally) performs its job efficiently, how well do they work with one another to support your practice?
As you go about your daily workflow, it is likely you deal with a wide variety of systems (perhaps an EMR software, dermoscopy analytics tools, teledermoscopy software, total body photography, clinical decision support tools to name a few).
Happy Birthday Canada! We’d like to celebrate today by sharing our appreciation for the Canadian government programs for all of their contributions towards new and growing companies like MetaOptima. With so many wonderful accomplishments, we’d like to take this opportunity to talk about how amazing Canada is for building innovative technologies that will have a global impact!
As the rates of skin cancer continue to rise in Canada, many family physicians have become the front line of defense for the early detection of these cases.1 Unfortunately, GPs have less experience detecting cancerous lesions than their dermatologist counterparts. How can dermoscopy tools provide a solution to this growing dissonance?
In part 2 of the article we discussed the cost efficacy of emerging cloud-based EMR software in contrast to the aging method of on-premise systems. The third and final step to completing this comparison is examining the actual capabilities provided by each of their systems: namely, once they are installed how are they supporting medical professionals in their practice? As with the last two articles, this will be examined through the lens of the dermoscopy industry.
When doctors implement or expand their practice, they have the opportunity to purchase from a wide variety of EMR systems. However, systems such as cloud-based and on-premise software operate in such contrasting ways that it can be hard to weigh the benefits of each. Part 2 of our EMR analysis will research the cost barriers and long-term efficacy of each type with a particular focus in the dermatology industry.
Recently, there has been one question in particular on the mind of every healthcare professional: how can I keep patient data secure? As technology rapidly evolves, this concern becomes intrinsically related to how health tech such as EMR software are equipped to handle the tsunami of changes facing the digital healthcare industry, particularly in the area of medical images and, in our case, dermoscopy.
Today was the final day of the World Congress of Dermoscopy! Over the last three days, word spread fast about it being last day to receive 50% off their MoleScope II alongside 6 FREE months of DermEngine. Read on to see how you can still experience this intelligent dermatology software for yourself.
Even busier than yesterday, the second day of the World Congress of Dermoscopy (WCD) at Booth #22 was packed with attendees eager to receive a demonstration of how DermEngine and MoleScope II can support their practice. If you haven't already signed up, read on to learn how you can receive 6 FREE months of DermEngine right now!
Today marked the first day of WCD 2018! Off to a fantastic start, the MetaOptima Team had a productive first day demoing DermEngine (our intelligent dermatology software) and MoleScope II (our mobile dermoscope) at Booth #22. Read on to find out what users thought of the latest upgrades to DermEngine!
The world of dermoscopy is rapidly evolving as intelligent dermatology software, tools, and innovations flood the market. Read on to discover the 5 innovations dominating the industry and how they will enhance the way you provide your services.
If you search for "Artificial Intelligence in Dermatology" news, you will likely be bombarded with articles asking questions such as "Will AI Replace Doctors?" or making broad statements such as "See Why AI Is The Next Big Thing In Dermatology". But what does this all mean? How will AI actually become integrated into the dermoscopy industry, and what does it mean for healthcare professionals?
The MetaOptima Team is thrilled to announce that Skin Capital and AirTree Ventures have invested $US 6.5 million in our company to support our continued journey of creating and developing intelligent dermoscopy tools for smart skin imaging, analytics, management, and skin cancer early detection!
The MetaOptima Team is gearing up for the World Congress of Dermoscopy 2018! Less than 11 days away, the 2018 congress will be held in Thessaloniki, Greece from June 14th-16th. This year we have a special discount for those who visit our booth (#22). Read on to find out how you can get a 6-month DermEngine subscription for free and walk away with 50% off your MoleScope II!
MetaOptima has recently updated its privacy policy! We'd like to take this opportunity to summarize how our company and its software (DermEngine & MoleScope) strictly adhere to all laws set out by the General Data Protection Regulation (GDPR). The GDPR defines the rights you as a patient have to your personal data.This includes but is not limited to your right to access your information, and knowledge as to whether or not your personal data is being processed.
How does you keep your patient’s data private and secure? As the technology sector continues to boom with the newest and greatest inventions in digital health and beyond, it is crucial that your data security is at the forefront of these upgrades. If you have any questions, we encourage you to read our Privacy Policy or email us at privacy@metaoptima.com.
We are excited to share that the MetaOptima Team is attending the Australasian Skin Cancer Congress from May 25th to 27th in Queensland, Australia. Additionally, last week AUS/NZ Sales Manager, Darren, CTO & Co-Founder, Majid Razmara, and CEO & Co-Founder, Maryam Sadeghi attended the Australasian College of Dermatology's 51st Annual Scientific Meeting from May 19th-22nd to network with key opinion leaders while discussing how intelligent dermatology software can support their practice.
MetaOptima is pleased to announce that its CEO and Co-Founder, Maryam Sadeghi has been officially announced as the newest member of the Mitacs Research Council, where her duties will include supporting the continued research and innovation of Mitacs events while building new ideas and opportunities for intelligent discussions.
This summer, members of the MetaOptima team will be travelling to Thessaloniki, Greece for the 5th annual World Congress of Dermoscopy! Although the conference is held from June 16th-18th, preparations are already well underway to get ready for this big event, where we will be showcasing the latest features of DermEngine and MoleScope II at Booth #22!
From May 14th-16th MetaOptima team members Jodi Rai and Karen Meohas will be showcasing MoleScope II (our mobile dermoscope) at the BC Tech Summit in Vancouver, Canada. In addition to demonstrating how MoleScope can support the practice of physicians, they will get to explore, learn, and discuss how tools powered by artificial intelligence (AI) and machine learning are enhancing the Canadian economy. Attending the BC Tech Summit? Visit us at the Wavefront booth today!
We are thrilled to announce that Maryam Sadeghi, CEO of MetaOptima will be speaking at Startup Grind's Women Leaders Event in Vancouver! Along with two other CEOs, Maryam will be chatting about the importance of developing intelligent dermoscopy tools in healthcare, and sharing her personal experience about the challenges and rewards of being a successful female CEO in the digital health supercluster industry here in British Columbia.
At New Zealand's Skin Cancer Symposium, dermatologists learned the latest news in dermoscopy, skin cancer and how intelligent dermatology software can support their practice. Here, our AUS/NZ Sales Director, Darren presented DermEngine's latest tools while offering an exclusive deal for attendees.
Cloud-based dermatology EMR software is set for rapid growth in the upcoming years. This article discusses the primary benefits of Cloud computing such as interoperability and data accessibility along with the challenges it must overcome for successful implementation.
Each year BC Business Magazine journeys to find the province's most innovative, hard-working, and impactful women in STEM careers (science, technology, engineering, & mathematics). We are proud to announce that our CEO and Co-Founder, Maryam Sadeghi was announced as BC's Most Influential Woman in Health Tech in 2018! We'd like to take this opportunity to congratulate her on this significant achievement and learn more about her journey to becoming a visionary leader in the field of digital health
We are excited to announce that MetaOptima Technology was announced as a winner of the Ready To Rocket contest in the area of Digital Health! We are truly honored to be recognized as one of the fastest-growing start ups in the health tech industry for our technologies (MoleScope, our mobile dermoscope and DermEngine, our intelligent dermatology software) and are thrilled to be a part of this alongside such innovative companies!
This year, MetaOptima applied to PwC's Vision to Reality (V2R) award program. Every year, PwC looks for the most forward-thinking organizations in the nation to join their vibrant community of innovators and become part of Canada's story. As part of the application/interview process, the MetaOptima Team is personally invited to join other applicants at the V2R pre-awards reception in Vancouver on Thursday, March 8th from 5:30 pm-9:00 pm at the Terminal City Club!
Recently, there has been a considerable amount of hype surrounding artificial intelligence (particularly in the field of dermatology), which primarily discusses the potential benefits/challenges of the technology along with expected release timelines. Today, we will be focusing on amazing technologies fueled by artificial intelligence (AI) in healthcare that are currently available to the dermatology industry and beyond. From here, efficacy, applications, and similarities between these innovatio
This month, British Columbia was chosen as one of five successful superclusters that will receive federal funding. Seen as a hub of Canadian invention, British Columbia's technology sector already generates $26 billion in annual revenue. With the support of federal government, ecosystems across Canada will flourish with innovation and economic growth, with a GDP growth of $15 billion over the next decade!
Starting June 15th, London Drugs Patient Care Pharmacists (PCPs) are available for one-on-one personal skin check appointments at select lower mainland London Drugs stores. During each clinical session, the PCPs will utilize Vancouver-based MetaOptima's non-invasive MoleScope device and will review the importance of the "ABCDE" method for mole checks.
The Honourable Judy M. Foote, Minister of Public Services and Procurement, today announced that the Government of Canada is investing in a made-in-Canada innovation that uses smartphones to help detect skin cancer.
In honor of the Melanoma Awareness Month, La Roche-Posay is holding its second annual Become a Skin Checker event in Montreal, in collaboration with MetaOptima Technology and Centre Medical Urbain.
Surrey’s RCMP officers and staff have a new weapon in their arsenal — the DermEngine skin-screening platform created by Simon Fraser University alumna Maryam Sadeghi.
MoleScope inventor Maryam Sadeghi is bringing affordable tech to the masses to empower self-monitoring and early detection of possible cancers in moles and skin blemishes.
Canadian company MetaOptima Technology Incorporated is one of five new companies to join MediCity, the UK’s rapidly-expanding innovation hub for consumer healthcare, medical technology, diagnostics and beauty products.
Designed to be user-friendly, Molescope guides the patient with educational materials and allows the high-quality images to be used by physicians, general practitioners and dermatology specialists for ongoing patient management.
A perfect example of the companies now starting to emerge from B.C.’s established biotechnology and life sciences industry is MetaOptima, which has developed and is marketing the MoleScope, a small device that attaches to a smartphone which can help patients and physicians track potentially cancerous moles.
A new device that attaches to your smartphone and uses high-definition imaging to help healthcare professionals assesses the health of your moles is being introduced this week at the 23rd World Congress of Dermatology in Vancouver, Canada.
Simon Fraser University PhD graduate Maryam Sadeghi will unveil MoleScope™, an innovative hand-held tool that uses a smartphone to monitor skin for signs of cancer, at the World Congress of Dermatology conference in Vancouver June 9-13.
A Simon Fraser University spinoff company has developed an app and a tiny microscope attachment for smartphones that allows users to take, store and share high quality images of moles and other suspicious skin lesions.
Rocket Builders today released its thirteenth annual “Ready to Rocket” lists. These lists profile British Columbia technology companies that are best positioned to capitalize on the technology sector trends that will lead them to faster growth than their peers.
Created to bolster innovation in Canada’s business sector, the Build in Canada Innovation Program (BCIP) helps companies bridge the pre-commercialization gap by procuring and testing late stage innovative goods and services within the federal government before taking them to market.” MetaOptima Technology’s DermEngine has been selected as one of 5 Pre-qualified innovations within the Health Sciences from Call for Proposals 005 which closed in September 2014.
On June 11th, 2014, MetaOptima competed in Plug and Play's Startup Showdown 2.0 in Vancouver, BC. Dr. Maryam Sadeghi, CEO, impressed the panel of judges with her pitch and placed first overall, winning a $25,000 investment and 3 months of office space and mentorship in Silicon Valley. Congratulations to all the winners!
Atkins is leading an SFUled initiative that, in 2013, created MoleScope, a tiny microscope used with a smartphone that snaps images of skin moles, a precursor of skin cancer, which afflicts six million new patients every year around the globe. MoleScope soft-ware stores images of moles, allowing physicians to monitor changes over time.
[Translation] More than just a simple microscope, the MoleScope system offers numerous features on its mobile app. In fact, this smartphone-attachable microscope allows the user to upload their mole images to a secure server and analyze any suspicious spots. [...] Even better, MoleScope allows the user to send their updated files and images to their doctor for review.
Melanoma is an increasingly common skin cancer that can be fatal if detected in an advanced stage. Today, innovation in skin cancer detection is taking a very high-tech turn. Maryam Sadeghi, of Simon Fraser University Surrey, near Vancouver, Canada is developing a smartphone-attachable imaging device for skin cancer screening called “MoleScope”...
The fight against skin cancer is enlisting the help of smartphones to monitor suspicious moles thanks to a Simon Fraser University grad's venture idea. The Coast Capital Savings Venture Prize Competition awarded Maryam Sadeghi, creator of the MoleScope technology, the top prize of $3,000 on February 12 after she pitched judges her business plan...
The MoleScope and UV Canada app, developed by Vancouver scientist Maryam Sadeghi, are designed to help Canadians identify skin cancer early. The technology is used to capture and record photos of potentially-cancerous moles and then share these images with medical specialists using cloud-based technology...
MoleScope Featured in Globe and Mail Skin cancer is both common and potentially deadly, with risks increasing the longer it goes undetected. So it made little sense to Maryam Sadeghi that people can wait days, weeks or even months to find out if suspicious moles were something to worry about. So she created MoleScope, a...
Maryam Sadeghi, founder of an award-winning health technology company, MetaOptima Technology Inc., is SFU’s 2013 Entrepreneur of the Year. Sadeghi was among 10 young SFU inventors who pitched their businesses in a Dragon’s Den-style competition before a panel of industry experts at SFU Surrey Nov. 16-17. Sadeghi also leads SFU’s new Digital Health Hub, based...
MetaOptima Technology Inc, a health technology company created by Simon Fraser University researcher Maryam Sadeghi, has won a top prize in the 2013 BCIC New Ventures Competition. The company received a $40,000 Wavefront Wireless prize package, finishing one of 10 companies shortlisted from nearly 150 applicants in this year’s competition...
As the sun continues to beat down this summer, the risk of being outdoors with no protection continues to grow. And it’s not just the temperature that plays a factor, but the UV rays that are emitted from the sun. “The main cause of skin cancer is UV rays. Too much sun exposure can cause skin cancer,” says Maryam Sadeghi with MetaOptima...
NSERC Innovation Challenge Award Maryam Sadeghi, who received her PhD in Computing Science from SFU this year, has been awarded a 2012 NSERC Innovation Challenge Award (Honourable Mention) for her innovative use of artificial intelligence and mobile technologies to improve prevention and early diagnosis of skin cancer. Dr. Sadeghi completed her doctoral studies in SFU’s...
Maryam Sadeghi has developed unique solutions for the prevention and early diagnosis of skin cancer by taking advantage of artificial intelligence using low-cost devices armed with mobile technologies, such as smart phones, for tele-dermatology. Her team has developed and launched UV Canada—a free public health education app for sun protection...